a2z Radiology AI vs Olay

Side-by-side comparison of AI visibility scores, market position, and capabilities

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Olay

LeaderBeauty & Personal Care

Skincare

P&G (PG) flagship mass-market skincare brand with retinol, niacinamide, and Amino-Peptide Complex across Regenerist and Luminous lines; competing with CeraVe and The Ordinary for skincare-educated consumers.

AI VisibilityBeta
Overall Score
A86
Category Rank
#2 of 3
AI Consensus
61%
Trend
stable
Per Platform
ChatGPT
82
Perplexity
96
Gemini
93

About

Olay is Procter & Gamble's flagship mass-market skincare brand — offering anti-aging moisturizers, serums, cleansers, and eye creams formulated with clinically validated ingredients including retinol, niacinamide, vitamin C, and the proprietary Amino-Peptide Complex across multiple product lines (Regenerist, Luminous, Total Effects, Age Defying) that target specific skin concerns from fine lines and uneven tone to dryness and dark spots. Owned by Procter & Gamble (NYSE: PG) and sold in 80+ countries, Olay generates billions in annual skincare revenue as one of P&G's most recognizable beauty brands.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.